The Medical Angiography X‑ray System segmentation by application isolates four primary end‑use domains: cardiology, neurology, peripheral vascular and oncology. Cardiology dominates the market, accounting for roughly 45 % of total revenue, driven by the high prevalence of coronary artery disease and the extensive adoption of coronary angiography in both diagnostic and interventional procedures. Neurology contributes about 30 % as neuro‑vascular imaging—particularly for stroke assessment and cerebral aneurysm treatment—requires high‑resolution, real‑time visualization, prompting hospitals to invest in dedicated angiography suites. Peripheral vascular applications, representing roughly 20 % of the market, support lower‑extremity and abdominal vessel assessments, where demand is fueled by an aging population and rising incidence of peripheral artery disease. The oncology segment, though smaller at an estimated 5 %, is growing due to emerging interventional radiology techniques for tumor embolization and chemo‑delivery that rely on precise X‑ray guidance. Collectively, these application categories shape the overall market size by dictating equipment specifications, pricing tiers, and service‑contract volumes.